Metabolic Modulators in Cardiovascular Disease Management

Abstract

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, driven in large part by the complex interactions among metabolic dysfunction, inflammation, and maladaptive cellular remodeling [...]